Laboratory Corporation of America Holdings is the 2nd clinical laboratory in the United States. Net sales (before intragroup eliminations) break down by activity as follows: – provision of clinical laboratory services (63.9%): performance of routine tests, patient diagnostics and disease monitoring and treatment services, etc.; ; – development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales break down geographically as follows: North America (81.2%), Europe (12.7%) and other (6.1%).
More information about the company
2023-09-06 12:02:54
#Laboratory #Corporation #America #Holdings #HSBC #downgrades #opinion #neutral